LNSR - NASDAQ
LENSAR, Inc.
$5.74
-2.0%LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
At a Glance
Live SnapshotLENSAR, Inc. Management Team
Mr. Thomas R. Staab II, CPA
Chief Financial Officer & Secretary
Compensation
$687,754
Mr. Alan B. Connaughton
Chief Operating Officer
Compensation
$734,241
Mr. Nicholas T. Curtis
President, Chief Executive Officer & Director
Compensation
$1,118,246
Ms. Kendra W. Wong
Principal Accounting Officer
LENSAR, Inc. Insider Positioning
During the last 12 months, there has been no insider trading activity reported for LNSR.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
No buying activity
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
No insider trading activity reported. This could indicate blackout periods, lack of conviction, or regulatory restrictions.
Insider Participation
No insider trading activity reported from any insiders in the past year.
SEC Filings
LNSR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | November 05, 2025 | October 24, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 25, 2024 | May 07, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | June 20, 2023 | August 01, 2023 | 2023 | |
DEF 14A DEF 14A 2023 N/A | April 12, 2023 | May 25, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 12, 2022 | May 25, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 05, 2021 | May 18, 2021 | 2021 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.